Mountain Pacific Investment Advisers Inc. ID Purchases 40,382 Shares of Hill-Rom Holdings, Inc. (HRC)

Mountain Pacific Investment Advisers Inc. ID raised its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 26.2% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 194,560 shares of the medical technology company’s stock after purchasing an additional 40,382 shares during the quarter. Hill-Rom accounts for 2.0% of Mountain Pacific Investment Advisers Inc. ID’s portfolio, making the stock its 19th biggest position. Mountain Pacific Investment Advisers Inc. ID’s holdings in Hill-Rom were worth $20,596,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the business. BlackRock Inc. lifted its position in Hill-Rom by 3.5% in the fourth quarter. BlackRock Inc. now owns 6,350,899 shares of the medical technology company’s stock valued at $562,371,000 after purchasing an additional 215,770 shares during the last quarter. Vanguard Group Inc lifted its position in Hill-Rom by 0.6% in the third quarter. Vanguard Group Inc now owns 5,916,827 shares of the medical technology company’s stock valued at $558,549,000 after purchasing an additional 34,369 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in Hill-Rom by 8,755.0% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 2,281,991 shares during the last quarter. Bank of Montreal Can lifted its position in Hill-Rom by 5.0% in the first quarter. Bank of Montreal Can now owns 1,724,410 shares of the medical technology company’s stock valued at $182,547,000 after purchasing an additional 81,956 shares during the last quarter. Finally, Fisher Asset Management LLC lifted its position in Hill-Rom by 0.6% in the fourth quarter. Fisher Asset Management LLC now owns 1,313,512 shares of the medical technology company’s stock valued at $116,311,000 after purchasing an additional 7,808 shares during the last quarter. Hedge funds and other institutional investors own 84.76% of the company’s stock.

Several analysts have weighed in on the company. Zacks Investment Research upgraded Hill-Rom from a “sell” rating to a “hold” rating in a research report on Tuesday, February 12th. Barclays upped their target price on Hill-Rom from $103.00 to $108.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Needham & Company LLC restated a “buy” rating and set a $116.00 target price on shares of Hill-Rom in a report on Monday, March 11th. Finally, ValuEngine downgraded Hill-Rom from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $109.88.

Shares of Hill-Rom stock traded down $0.91 during midday trading on Friday, reaching $98.19. 759 shares of the company’s stock traded hands, compared to its average volume of 563,854. The company has a quick ratio of 1.27, a current ratio of 1.69 and a debt-to-equity ratio of 1.10. The company has a market cap of $6.62 billion, a PE ratio of 20.69, a P/E/G ratio of 1.69 and a beta of 0.91. Hill-Rom Holdings, Inc. has a 12 month low of $81.82 and a 12 month high of $108.68.

Hill-Rom (NYSE:HRC) last announced its earnings results on Friday, April 26th. The medical technology company reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.03. The company had revenue of $714.20 million during the quarter, compared to the consensus estimate of $705.59 million. Hill-Rom had a return on equity of 21.30% and a net margin of 7.93%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.05 earnings per share. On average, research analysts anticipate that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 21st will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, June 20th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.86%. Hill-Rom’s dividend payout ratio is presently 17.68%.

TRADEMARK VIOLATION NOTICE: “Mountain Pacific Investment Advisers Inc. ID Purchases 40,382 Shares of Hill-Rom Holdings, Inc. (HRC)” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/17/mountain-pacific-investment-advisers-inc-id-purchases-40382-shares-of-hill-rom-holdings-inc-hrc.html.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Recommended Story: How is an ETF different from a mutual fund?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.